The global burden of chronic kidney disease (CKD) is rising, with more than 800 million people affected worldwide. Vascular diseases in patients with CKD are unique and grouped as uremic vascular ...

In his inaugural address, President Daniel Coit Gilman, the University’s first president, made a statement on what he expects ...

Researchers at Hopkins have made strides in pancreatic cancer research, both in understanding age-related differences in ...

Luminopia, Inc., a digital health company pioneering a new class of treatments for neuro-visual disorders, today announced that the U.S. Food & Drug Administration (FDA) cleared its amblyopia ...

An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) treatments by helping infected cells die a gentler death, Johns Hopkins ...

The sprawling St. Petersburg campus sustained $1.51 million in damage during hurricanes Helene and Milton. About 200 children ...